Merck Signs Another Deal with 4D Pharma to Strengthen its Vaccine Portfolio

By Sharath Chandra Nakka

Pharma Deals Review: Vol 2019 Issue 10 (Table of Contents)

Published: 26 Oct-2019

DOI: 10.3833/pdr.v2019.i10.2466     ISSN: 1756-7874

Section: Research & Development



Merck Sharp & Dohme has entered into a research collaboration with UK-based 4D Pharma to discover and develop up to three vaccine candidates by using the latter’s proprietary platform - MicroRx...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details